Ionis Pharmaceuticals (IONS) Interest Expenses (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Interest Expenses of $16.6 million for Q2 2026, up 93.02% year-over-year from $8.6 million in Q2 2025, and down 5.68% quarter-over-quarter from $17.6 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Interest Expenses (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Interest Expenses history runs 18 years deep, the most recent figure standing at $16.6 million for Q2 2026.
- In Q2 2026, Interest Expenses rose 93.02% year-over-year to $16.6 million; the TTM figure through Jun 2026 stood at $16.6 million (up 93.02% YoY), while the FY2025 annual figure was $1.2 billion, up 9.49% from the prior year.
- Interest Expenses for Q2 2026 stood at $16.6 million, down from $17.6 million in the prior quarter.
- The five-year high for Interest Expenses was $230.0 million in Q3 2025, with the low at -$1.6 million in Q4 2023.
- The 5-year median for Interest Expenses is $14.1 million (2023), against an average of $25.8 million.
- The sharpest annual moves came in 2023 and 2025: Interest Expenses sank 126.87% in 2023, then soared 2049.53% in 2025.
- Ionis Pharmaceuticals' Interest Expenses stood at $5.9 million in 2022, then tumbled by 126.87% to -$1.6 million in 2023, then surged by 424.21% to $5.2 million in 2024, then climbed by 4.42% to $5.4 million in 2025, then surged by 208.38% to $16.6 million in 2026.
- Business Quant data shows IONS's Interest Expenses at $16.6 million in Q2 2026, $17.6 million in Q1 2026, and $5.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 16.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.60 Mn |
| Jun 30, 2026 | 16.60 Mn |
| Mar 31, 2026 | 17.60 Mn |
| Mar 31, 2026 | 17.60 Mn |
| Dec 31, 2025 | 5.38 Mn |
| Dec 31, 2025 | 5.38 Mn |
| Sep 30, 2025 | 230.00 Mn |
| Sep 30, 2025 | 230.00 Mn |
| Jun 30, 2025 | 8.60 Mn |
| Jun 30, 2025 | 8.60 Mn |
| Mar 31, 2025 | 9.30 Mn |
| Mar 31, 2025 | 9.30 Mn |
| Dec 31, 2024 | 5.16 Mn |
| Dec 31, 2024 | 5.16 Mn |
| Sep 30, 2024 | 10.70 Mn |
| Sep 30, 2024 | 10.70 Mn |
| Jun 30, 2024 | 11.40 Mn |
| Jun 30, 2024 | 11.40 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Mar 31, 2024 | 12.00 Mn |